Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes
Deng X, Zhang C, Wang P, et al.
J Clin Endocrinol Metab. 2022;107(7):1888-1896.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Deng X, Zhang C, Wang P, et al.
J Clin Endocrinol Metab. 2022;107(7):1888-1896.
Leggi
Ciardullo S, Rea F, Savaré L, et al.
J Clin Endocrinol Metab. 2022;107(7):e2671-e2679.
Leggi
Grespan E, Guolo A, Muscelli E, et al.
J Clin Endocrinol Metab. 2022;107(7):2092-2100.
Leggi
Au PCM, Tan KCB, Cheung BMY, et al.
J Clin Endocrinol Metab. 2022;107(7):e2962-e2970.
Leggi
Schiborn C, Schulze MB
Diabetologia. Pub. online 21 Jun 2022.
Leggi
Flatt AJ, Chen E, Peleckis AJ, et al.
Diabetes Technol Ther. Pub. online 27 Jun 2022.
Leggi
Forlenza GP, Carlson AL, Galindo R et al
Diabetes Technol Ther. Pub. online 28 Jun 2022.
Leggi
Messer LH, Buckingham BA, Cogen F, et al.
Diabetes Technol Ther. Pub. online 28 Jun 2022.
Leggi
Zeng Y, Yang Y, Guan CJ, et al.
BMC Endocr Disord. 2022;22(1):168
Leggi
Montaser E, Fabris C, Kovatchev BP
Diabetes Technol Ther. Pub. online 17 Jun 2022
Leggi